HEADER TRANSFERASE/TRANSFERASE INHIBITOR 16-DEC-10 3Q0Z
TITLE CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA
TITLE 2 POLYMERASE COMPLEX WITH (2E)-3-(4-{[(1-{[(13-CYCLOHEXYL-6-OXO-6,7-
TITLE 3 DIHYDRO-5H-INDOLO[1,2-D][1,4]BENZODIAZEPIN-10-YL)
TITLE 4 CARBONYL]AMINO}CYCLOPENTYL)CARBONYL]AMINO}PHENYL)PROP-2-ENOIC ACID
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: RNA-DIRECTED RNA POLYMERASE;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: NS5B, P68;
COMPND 5 EC: 2.7.7.48;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS SUBTYPE 1B;
SOURCE 3 ORGANISM_TAXID: 31647;
SOURCE 4 STRAIN: BARTENSCHLAGER;
SOURCE 5 GENE: NS5B;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) STAR;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21B
KEYWDS NS5B, POLYMERASE, HCV, FINGERS, PALM, THUMB, TRANSFERASE,
KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR S.SHERIFF
REVDAT 3 13-SEP-23 3Q0Z 1 REMARK SEQADV
REVDAT 2 11-MAY-11 3Q0Z 1 JRNL
REVDAT 1 27-APR-11 3Q0Z 0
JRNL AUTH X.ZHENG,T.W.HUDYMA,S.W.MARTIN,C.BERGSTROM,M.DING,F.HE,
JRNL AUTH 2 J.ROMINE,M.A.POSS,J.F.KADOW,C.H.CHANG,J.WAN,M.R.WITMER,
JRNL AUTH 3 P.MORIN,D.M.CAMAC,S.SHERIFF,B.R.BENO,K.L.RIGAT,Y.K.WANG,
JRNL AUTH 4 R.FRIDELL,J.LEMM,D.QIU,M.LIU,S.VOSS,L.PELOSI,S.B.ROBERTS,
JRNL AUTH 5 M.GAO,J.KNIPE,R.G.GENTLES
JRNL TITL SYNTHESES AND INITIAL EVALUATION OF A SERIES OF INDOLO-FUSED
JRNL TITL 2 HETEROCYCLIC INHIBITORS OF THE POLYMERASE ENZYME (NS5B) OF
JRNL TITL 3 THE HEPATITIS C VIRUS.
JRNL REF BIOORG.MED.CHEM.LETT. V. 21 2925 2011
JRNL REFN ISSN 0960-894X
JRNL PMID 21486696
JRNL DOI 10.1016/J.BMCL.2011.03.067
REMARK 2
REMARK 2 RESOLUTION. 2.29 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.9.4
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.08
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9
REMARK 3 NUMBER OF REFLECTIONS : 62918
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.201
REMARK 3 R VALUE (WORKING SET) : 0.200
REMARK 3 FREE R VALUE : 0.224
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.460
REMARK 3 FREE R VALUE TEST SET COUNT : 919
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.35
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.92
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4667
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2314
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4610
REMARK 3 BIN R VALUE (WORKING SET) : 0.2310
REMARK 3 BIN FREE R VALUE : 0.2645
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 1.22
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 57
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 8480
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 144
REMARK 3 SOLVENT ATOMS : 509
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 43.27
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.06
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -10.93140
REMARK 3 B22 (A**2) : 3.73570
REMARK 3 B33 (A**2) : 7.19570
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.281
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 8812 ; 2.000 ; NULL
REMARK 3 BOND ANGLES : 11978 ; 2.000 ; NULL
REMARK 3 TORSION ANGLES : 2990 ; 2.000 ; NULL
REMARK 3 TRIGONAL CARBON PLANES : 163 ; 2.000 ; NULL
REMARK 3 GENERAL PLANES : 1306 ; 5.000 ; NULL
REMARK 3 ISOTROPIC THERMAL FACTORS : 8812 ; 20.000 ; NULL
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 1154 ; 5.000 ; NULL
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 10313 ; 4.000 ; NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.06
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.09
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.65
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 3Q0Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-11.
REMARK 100 THE DEPOSITION ID IS D_1000063057.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 06-FEB-05
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.6
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : VARIMAX CONFOCAL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 (DENZO)
REMARK 200 DATA SCALING SOFTWARE : HKL-2000 (SCALEPACK)
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63158
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0
REMARK 200 DATA REDUNDANCY : 8.900
REMARK 200 R MERGE (I) : 0.13300
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6
REMARK 200 DATA REDUNDANCY IN SHELL : 8.00
REMARK 200 R MERGE FOR SHELL (I) : 0.79900
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.800
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: PDB ENTRY 1C2P
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 55.17
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.6, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.15000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 115.85000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.70000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 115.85000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.15000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.70000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2590 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 45890 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -118.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 66.30000
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -45.70000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 115.85000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 0
REMARK 465 ALA A 15
REMARK 465 ALA A 16
REMARK 465 GLU A 17
REMARK 465 GLU A 18
REMARK 465 THR A 19
REMARK 465 LYS A 20
REMARK 465 LEU A 21
REMARK 465 PRO A 22
REMARK 465 ILE A 23
REMARK 465 ASN A 24
REMARK 465 ALA A 25
REMARK 465 LEU A 26
REMARK 465 SER A 27
REMARK 465 ASN A 28
REMARK 465 SER A 29
REMARK 465 LEU A 30
REMARK 465 LEU A 31
REMARK 465 ARG A 32
REMARK 465 HIS A 33
REMARK 465 HIS A 34
REMARK 465 ASN A 35
REMARK 465 LEU A 36
REMARK 465 MET B 0
REMARK 465 ALA B 15
REMARK 465 ALA B 16
REMARK 465 GLU B 17
REMARK 465 GLU B 18
REMARK 465 THR B 19
REMARK 465 LYS B 20
REMARK 465 LEU B 21
REMARK 465 PRO B 22
REMARK 465 ILE B 23
REMARK 465 ASN B 24
REMARK 465 ALA B 25
REMARK 465 LEU B 26
REMARK 465 SER B 27
REMARK 465 ASN B 28
REMARK 465 SER B 29
REMARK 465 LEU B 30
REMARK 465 LEU B 31
REMARK 465 ARG B 32
REMARK 465 HIS B 33
REMARK 465 HIS B 34
REMARK 465 ASN B 35
REMARK 465 LEU B 36
REMARK 465 ARG B 568
REMARK 465 PRO B 569
REMARK 465 ARG B 570
REMARK 465 TRP B 571
REMARK 465 PHE B 572
REMARK 465 MET B 573
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 VAL A 37 CG1 CG2
REMARK 470 LEU A 57 CG CD1 CD2
REMARK 470 LYS A 100 CD CE NZ
REMARK 470 GLU A 131 CG CD OE1 OE2
REMARK 470 VAL A 147 CG1 CG2
REMARK 470 LYS A 355 CG CD CE NZ
REMARK 470 LYS A 535 CE NZ
REMARK 470 ARG A 568 CG CD NE CZ NH1 NH2
REMARK 470 VAL B 37 CG1 CG2
REMARK 470 LEU B 57 CG CD1 CD2
REMARK 470 LYS B 90 CD CE NZ
REMARK 470 LYS B 100 CD CE NZ
REMARK 470 GLU B 131 CG CD OE1 OE2
REMARK 470 VAL B 147 CG1 CG2
REMARK 470 LYS B 355 CG CD CE NZ
REMARK 470 LYS B 535 CG CD CE NZ
REMARK 470 ARG B 566 CG CD NE CZ NH1 NH2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLU A 131 -31.60 -131.96
REMARK 500 LEU A 260 -56.99 -124.46
REMARK 500 SER A 347 60.97 70.24
REMARK 500 ALA A 348 55.45 -157.51
REMARK 500 ILE A 424 -60.18 -98.58
REMARK 500 PHE A 551 66.90 -118.80
REMARK 500 TYR A 555 25.32 -140.43
REMARK 500 ARG A 568 76.09 61.80
REMARK 500 LEU B 260 -56.89 -126.21
REMARK 500 SER B 347 61.27 70.59
REMARK 500 ALA B 348 54.60 -157.37
REMARK 500 ILE B 424 -61.15 -97.75
REMARK 500 LEU B 536 89.00 73.22
REMARK 500 PHE B 551 66.59 -118.32
REMARK 500 TYR B 555 24.77 -140.94
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 23E A 601
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 651
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 652
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 653
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 654
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 655
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 23E B 601
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 651
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 652
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 653
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 656
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 657
DBREF 3Q0Z A 1 573 UNP Q9WMX2 POLG_HCVCO 2420 2992
DBREF 3Q0Z B 1 573 UNP Q9WMX2 POLG_HCVCO 2420 2992
SEQADV 3Q0Z MET A 0 UNP Q9WMX2 INITIATING METHIONINE
SEQADV 3Q0Z MET B 0 UNP Q9WMX2 INITIATING METHIONINE
SEQRES 1 A 574 MET SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR
SEQRES 2 A 574 PRO CYS ALA ALA GLU GLU THR LYS LEU PRO ILE ASN ALA
SEQRES 3 A 574 LEU SER ASN SER LEU LEU ARG HIS HIS ASN LEU VAL TYR
SEQRES 4 A 574 ALA THR THR SER ARG SER ALA SER LEU ARG GLN LYS LYS
SEQRES 5 A 574 VAL THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR
SEQRES 6 A 574 ARG ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR
SEQRES 7 A 574 VAL LYS ALA LYS LEU LEU SER VAL GLU GLU ALA CYS LYS
SEQRES 8 A 574 LEU THR PRO PRO HIS SER ALA ARG SER LYS PHE GLY TYR
SEQRES 9 A 574 GLY ALA LYS ASP VAL ARG ASN LEU SER SER LYS ALA VAL
SEQRES 10 A 574 ASN HIS ILE ARG SER VAL TRP LYS ASP LEU LEU GLU ASP
SEQRES 11 A 574 THR GLU THR PRO ILE ASP THR THR ILE MET ALA LYS ASN
SEQRES 12 A 574 GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS
SEQRES 13 A 574 PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG
SEQRES 14 A 574 VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR
SEQRES 15 A 574 LEU PRO GLN ALA VAL MET GLY SER SER TYR GLY PHE GLN
SEQRES 16 A 574 TYR SER PRO GLY GLN ARG VAL GLU PHE LEU VAL ASN ALA
SEQRES 17 A 574 TRP LYS ALA LYS LYS CYS PRO MET GLY PHE ALA TYR ASP
SEQRES 18 A 574 THR ARG CYS PHE ASP SER THR VAL THR GLU ASN ASP ILE
SEQRES 19 A 574 ARG VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA
SEQRES 20 A 574 PRO GLU ALA ARG GLN ALA ILE ARG SER LEU THR GLU ARG
SEQRES 21 A 574 LEU TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN
SEQRES 22 A 574 ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU
SEQRES 23 A 574 THR THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS
SEQRES 24 A 574 ALA ALA ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS
SEQRES 25 A 574 THR MET LEU VAL CYS GLY ASP ASP LEU VAL VAL ILE CYS
SEQRES 26 A 574 GLU SER ALA GLY THR GLN GLU ASP GLU ALA SER LEU ARG
SEQRES 27 A 574 ALA PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO
SEQRES 28 A 574 GLY ASP PRO PRO LYS PRO GLU TYR ASP LEU GLU LEU ILE
SEQRES 29 A 574 THR SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA
SEQRES 30 A 574 SER GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR
SEQRES 31 A 574 THR PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS
SEQRES 32 A 574 THR PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET TYR
SEQRES 33 A 574 ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS
SEQRES 34 A 574 PHE PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS
SEQRES 35 A 574 ALA LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE
SEQRES 36 A 574 GLU PRO LEU ASP LEU PRO GLN ILE ILE GLN ARG LEU HIS
SEQRES 37 A 574 GLY LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY
SEQRES 38 A 574 GLU ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY
SEQRES 39 A 574 VAL PRO PRO LEU ARG VAL TRP ARG HIS ARG ALA ARG SER
SEQRES 40 A 574 VAL ARG ALA ARG LEU LEU SER GLN GLY GLY ARG ALA ALA
SEQRES 41 A 574 THR CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL ARG THR
SEQRES 42 A 574 LYS LEU LYS LEU THR PRO ILE PRO ALA ALA SER GLN LEU
SEQRES 43 A 574 ASP LEU SER SER TRP PHE VAL ALA GLY TYR SER GLY GLY
SEQRES 44 A 574 ASP ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG TRP
SEQRES 45 A 574 PHE MET
SEQRES 1 B 574 MET SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR
SEQRES 2 B 574 PRO CYS ALA ALA GLU GLU THR LYS LEU PRO ILE ASN ALA
SEQRES 3 B 574 LEU SER ASN SER LEU LEU ARG HIS HIS ASN LEU VAL TYR
SEQRES 4 B 574 ALA THR THR SER ARG SER ALA SER LEU ARG GLN LYS LYS
SEQRES 5 B 574 VAL THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR
SEQRES 6 B 574 ARG ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR
SEQRES 7 B 574 VAL LYS ALA LYS LEU LEU SER VAL GLU GLU ALA CYS LYS
SEQRES 8 B 574 LEU THR PRO PRO HIS SER ALA ARG SER LYS PHE GLY TYR
SEQRES 9 B 574 GLY ALA LYS ASP VAL ARG ASN LEU SER SER LYS ALA VAL
SEQRES 10 B 574 ASN HIS ILE ARG SER VAL TRP LYS ASP LEU LEU GLU ASP
SEQRES 11 B 574 THR GLU THR PRO ILE ASP THR THR ILE MET ALA LYS ASN
SEQRES 12 B 574 GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS
SEQRES 13 B 574 PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG
SEQRES 14 B 574 VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR
SEQRES 15 B 574 LEU PRO GLN ALA VAL MET GLY SER SER TYR GLY PHE GLN
SEQRES 16 B 574 TYR SER PRO GLY GLN ARG VAL GLU PHE LEU VAL ASN ALA
SEQRES 17 B 574 TRP LYS ALA LYS LYS CYS PRO MET GLY PHE ALA TYR ASP
SEQRES 18 B 574 THR ARG CYS PHE ASP SER THR VAL THR GLU ASN ASP ILE
SEQRES 19 B 574 ARG VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA
SEQRES 20 B 574 PRO GLU ALA ARG GLN ALA ILE ARG SER LEU THR GLU ARG
SEQRES 21 B 574 LEU TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN
SEQRES 22 B 574 ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU
SEQRES 23 B 574 THR THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS
SEQRES 24 B 574 ALA ALA ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS
SEQRES 25 B 574 THR MET LEU VAL CYS GLY ASP ASP LEU VAL VAL ILE CYS
SEQRES 26 B 574 GLU SER ALA GLY THR GLN GLU ASP GLU ALA SER LEU ARG
SEQRES 27 B 574 ALA PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO
SEQRES 28 B 574 GLY ASP PRO PRO LYS PRO GLU TYR ASP LEU GLU LEU ILE
SEQRES 29 B 574 THR SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA
SEQRES 30 B 574 SER GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR
SEQRES 31 B 574 THR PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS
SEQRES 32 B 574 THR PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET TYR
SEQRES 33 B 574 ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS
SEQRES 34 B 574 PHE PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS
SEQRES 35 B 574 ALA LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE
SEQRES 36 B 574 GLU PRO LEU ASP LEU PRO GLN ILE ILE GLN ARG LEU HIS
SEQRES 37 B 574 GLY LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY
SEQRES 38 B 574 GLU ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY
SEQRES 39 B 574 VAL PRO PRO LEU ARG VAL TRP ARG HIS ARG ALA ARG SER
SEQRES 40 B 574 VAL ARG ALA ARG LEU LEU SER GLN GLY GLY ARG ALA ALA
SEQRES 41 B 574 THR CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL ARG THR
SEQRES 42 B 574 LYS LEU LYS LEU THR PRO ILE PRO ALA ALA SER GLN LEU
SEQRES 43 B 574 ASP LEU SER SER TRP PHE VAL ALA GLY TYR SER GLY GLY
SEQRES 44 B 574 ASP ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG TRP
SEQRES 45 B 574 PHE MET
HET 23E A 601 47
HET SO4 A 651 5
HET SO4 A 652 5
HET SO4 A 653 5
HET SO4 A 654 5
HET SO4 A 655 5
HET 23E B 601 47
HET SO4 B 651 5
HET SO4 B 652 5
HET SO4 B 653 5
HET SO4 B 656 5
HET SO4 B 657 5
HETNAM 23E (2E)-3-(4-{[(1-{[(13-CYCLOHEXYL-6-OXO-6,7-DIHYDRO-5H-
HETNAM 2 23E INDOLO[1,2-D][1,4]BENZODIAZEPIN-10-YL)
HETNAM 3 23E CARBONYL]AMINO}CYCLOPENTYL)CARBONYL]AMINO}PHENYL)PROP-
HETNAM 4 23E 2-ENOIC ACID
HETNAM SO4 SULFATE ION
FORMUL 3 23E 2(C38 H38 N4 O5)
FORMUL 4 SO4 10(O4 S 2-)
FORMUL 15 HOH *509(H2 O)
HELIX 1 1 THR A 41 ARG A 43 5 3
HELIX 2 2 SER A 44 THR A 53 1 10
HELIX 3 3 ASP A 61 SER A 76 1 16
HELIX 4 4 SER A 84 LEU A 91 1 8
HELIX 5 5 GLY A 104 ASN A 110 1 7
HELIX 6 6 SER A 112 ASP A 129 1 18
HELIX 7 7 ASP A 164 GLY A 188 1 25
HELIX 8 8 SER A 189 TYR A 195 5 7
HELIX 9 9 SER A 196 ALA A 210 1 15
HELIX 10 10 CYS A 223 VAL A 228 1 6
HELIX 11 11 THR A 229 GLN A 241 1 13
HELIX 12 12 ALA A 246 LEU A 260 1 15
HELIX 13 13 THR A 286 ALA A 306 1 21
HELIX 14 14 GLY A 328 TYR A 346 1 19
HELIX 15 15 ASP A 359 ILE A 363 5 5
HELIX 16 16 PRO A 388 ARG A 401 1 14
HELIX 17 17 ASN A 406 TYR A 415 1 10
HELIX 18 18 THR A 418 ILE A 424 1 7
HELIX 19 19 ILE A 424 GLU A 437 1 14
HELIX 20 20 GLU A 455 LEU A 457 5 3
HELIX 21 21 ASP A 458 GLY A 468 1 11
HELIX 22 22 LEU A 469 SER A 473 5 5
HELIX 23 23 SER A 478 LEU A 492 1 15
HELIX 24 24 PRO A 496 GLN A 514 1 19
HELIX 25 25 GLY A 515 PHE A 526 1 12
HELIX 26 26 ASN A 527 VAL A 530 5 4
HELIX 27 27 ILE A 539 SER A 543 5 5
HELIX 28 28 THR B 41 ARG B 43 5 3
HELIX 29 29 SER B 44 THR B 53 1 10
HELIX 30 30 ASP B 61 SER B 76 1 16
HELIX 31 31 SER B 84 LEU B 91 1 8
HELIX 32 32 GLY B 104 ASN B 110 1 7
HELIX 33 33 SER B 112 ASP B 129 1 18
HELIX 34 34 ASP B 164 GLY B 188 1 25
HELIX 35 35 SER B 189 TYR B 195 5 7
HELIX 36 36 SER B 196 ALA B 210 1 15
HELIX 37 37 CYS B 223 VAL B 228 1 6
HELIX 38 38 THR B 229 GLN B 241 1 13
HELIX 39 39 ALA B 246 LEU B 260 1 15
HELIX 40 40 THR B 286 ALA B 306 1 21
HELIX 41 41 GLY B 328 TYR B 346 1 19
HELIX 42 42 ASP B 359 ILE B 363 5 5
HELIX 43 43 PRO B 388 ARG B 401 1 14
HELIX 44 44 ASN B 406 TYR B 415 1 10
HELIX 45 45 THR B 418 ILE B 424 1 7
HELIX 46 46 ILE B 424 GLU B 437 1 14
HELIX 47 47 GLU B 455 LEU B 457 5 3
HELIX 48 48 ASP B 458 GLY B 468 1 11
HELIX 49 49 LEU B 469 SER B 473 5 5
HELIX 50 50 SER B 478 LEU B 492 1 15
HELIX 51 51 PRO B 496 GLN B 514 1 19
HELIX 52 52 GLY B 515 PHE B 526 1 12
HELIX 53 53 ASN B 527 VAL B 530 5 4
HELIX 54 54 ILE B 539 SER B 543 5 5
SHEET 1 A 5 TYR A 4 TRP A 6 0
SHEET 2 A 5 ASN A 273 ARG A 277 -1 O TYR A 276 N THR A 5
SHEET 3 A 5 GLY A 264 THR A 267 -1 N LEU A 266 O CYS A 274
SHEET 4 A 5 THR A 136 ALA A 140 1 N ILE A 138 O THR A 267
SHEET 5 A 5 LEU A 159 PHE A 162 -1 O ILE A 160 N MET A 139
SHEET 1 B 2 TYR A 38 ALA A 39 0
SHEET 2 B 2 VAL A 144 PHE A 145 -1 O PHE A 145 N TYR A 38
SHEET 1 C 3 PRO A 214 TYR A 219 0
SHEET 2 C 3 ASP A 319 GLU A 325 -1 O CYS A 324 N MET A 215
SHEET 3 C 3 GLN A 309 CYS A 316 -1 N THR A 312 O ILE A 323
SHEET 1 D 2 ASN A 369 HIS A 374 0
SHEET 2 D 2 ARG A 380 THR A 385 -1 O TYR A 383 N SER A 371
SHEET 1 E 3 LEU A 443 ILE A 447 0
SHEET 2 E 3 ALA A 450 ILE A 454 -1 O TYR A 452 N CYS A 445
SHEET 3 E 3 TYR A 561 SER A 563 1 O HIS A 562 N CYS A 451
SHEET 1 F 2 LEU A 545 ASP A 546 0
SHEET 2 F 2 SER A 565 ARG A 566 -1 O SER A 565 N ASP A 546
SHEET 1 G 5 TYR B 4 TRP B 6 0
SHEET 2 G 5 ASN B 273 ARG B 277 -1 O TYR B 276 N THR B 5
SHEET 3 G 5 GLY B 264 THR B 267 -1 N LEU B 266 O GLY B 275
SHEET 4 G 5 THR B 136 ALA B 140 1 N ILE B 138 O THR B 267
SHEET 5 G 5 LEU B 159 PHE B 162 -1 O ILE B 160 N MET B 139
SHEET 1 H 2 TYR B 38 ALA B 39 0
SHEET 2 H 2 VAL B 144 PHE B 145 -1 O PHE B 145 N TYR B 38
SHEET 1 I 3 PRO B 214 TYR B 219 0
SHEET 2 I 3 ASP B 319 GLU B 325 -1 O CYS B 324 N MET B 215
SHEET 3 I 3 GLN B 309 CYS B 316 -1 N THR B 312 O ILE B 323
SHEET 1 J 2 ASN B 369 HIS B 374 0
SHEET 2 J 2 ARG B 380 THR B 385 -1 O THR B 385 N ASN B 369
SHEET 1 K 3 LEU B 443 ILE B 447 0
SHEET 2 K 3 ALA B 450 ILE B 454 -1 O ILE B 454 N LEU B 443
SHEET 3 K 3 TYR B 561 SER B 563 1 O HIS B 562 N CYS B 451
SHEET 1 L 2 LEU B 545 ASP B 546 0
SHEET 2 L 2 SER B 565 ARG B 566 -1 O SER B 565 N ASP B 546
SITE 1 AC1 15 LEU A 392 ALA A 395 ALA A 396 ILE A 424
SITE 2 AC1 15 HIS A 428 LEU A 492 GLY A 493 VAL A 494
SITE 3 AC1 15 PRO A 495 PRO A 496 ARG A 498 VAL A 499
SITE 4 AC1 15 ARG A 503 23E B 601 HOH B 717
SITE 1 AC2 5 SER A 84 VAL A 85 ARG A 120 HOH A 757
SITE 2 AC2 5 HOH A 763
SITE 1 AC3 6 ARG A 48 LYS A 51 THR A 221 ARG A 222
SITE 2 AC3 6 CYS A 223 HOH A 808
SITE 1 AC4 5 HIS A 374 SER A 476 GLY A 516 ARG A 517
SITE 2 AC4 5 HOH A 760
SITE 1 AC5 5 PRO A 496 LEU A 497 ARG A 498 ARG A 570
SITE 2 AC5 5 HOH A 803
SITE 1 AC6 5 SER A 371 SER A 478 LYS A 523 HOH A 849
SITE 2 AC6 5 HOH A 944
SITE 1 AC7 18 ALA A 400 ARG A 401 HIS A 428 23E A 601
SITE 2 AC7 18 LEU B 392 ALA B 395 ALA B 396 ILE B 424
SITE 3 AC7 18 HIS B 428 LEU B 492 GLY B 493 VAL B 494
SITE 4 AC7 18 PRO B 495 PRO B 496 ARG B 498 ARG B 503
SITE 5 AC7 18 HOH B 717 HOH B 794
SITE 1 AC8 4 SER B 84 VAL B 85 ARG B 120 HOH B 854
SITE 1 AC9 3 ARG B 48 LYS B 51 CYS B 223
SITE 1 BC1 3 GLY B 516 ARG B 517 HOH B 824
SITE 1 BC2 4 SER A 1 LYS B 379 ARG B 380 HOH B 846
SITE 1 BC3 3 HIS B 475 SER B 476 HOH B 783
CRYST1 66.300 91.400 231.700 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015083 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010941 0.000000 0.00000
SCALE3 0.000000 0.000000 0.004316 0.00000